IAC Webinar in May 2021
Postponed. New date to be announced soon.
New dates to be arranged. The times remain: 7AM and repeated at 5PM. Central European Summer Time. (Link to World Clock©)
Thyroid FNA and the Bethesda System: What possibilities are there to perform molecular tests?
Massimo Bongiovanni, MD, Synlab Pathology, Lausanne, Switzerland
Seminar at 7AM Central European Time
Link to meeting
Repeat Seminar at 5PM Central European Time
In 2017 the second edition of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) was released. The new version incorporated the re-classification done by the WHO of some thyroid papillary carcinomas into the NIFTP (noninvasive follicular thyroid neoplasm with papillary-like nuclear features), that has implications for the risk of malignancy and for the diagnostic criteria. Moreover, new management options concerning molecular test were introduced for some diagnostic categories.
This webinar will concentrate in the new updates (as in the second edition) of TBSRTC concerning the diagnostic categories and when and how apply molecular test to cytological specimens. Different possibilities available on the marker will be analyzed and compared with test that can be performed in house.
Massimo Bongiovanni, MD, MIAC
Dr. Bongiovanni is head of Cytopathology at SYNLAB Pathology in Lausanne, Switzerland.
He is member of the Pathology Expert Group, at SYNLAB International and Member of the International Academy of Cytology (MIAC) since 2016.
Dr Bongiovanni completed his medical studies in 1997 and his residency in Pathology in 2002 at the University of Turin in Italy. In 2003, he joined the Institute of Pathology at the University Hospital of Geneva (HUG), where he began his scientific and clinical work in the field of pathology and cytopathology. After gaining experience in Ticino as deputy director of the Cantonal Institute of Pathology (2010-2014), he was appointed as associate professor and head of the Department of Cytopathology at the Institute of Pathology of the University Hospital of Lausanne (CHUV, 2014).
He is the author of more than 160 scientific articles and 15 book chapters. He is currently vice-president of the Swiss Society of Cytology and head of the scientific committee of the European Federation of Cytology Societies (EFCS).